Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How basal are triple-negative breast cancers?

International journal of cancer - 1 Jul 2008

Bertucci François, Finetti Pascal, Cervera Nathalie, Esterni Benjamin, Hermitte Fabienne, Viens Patrice, Birnbaum Daniel

Abstract excerpt

The basal molecular subtype of breast cancer (BC) is defined by the mRNA expression pattern of an intrinsic approximately 500-gene set. It is the most homogeneous subtype in transcriptional terms, and one of the most aggressive in prognostic terms. Clinical trials testing new systemic therapeutic strategies have been launched in basal BCs. Although no proof of evidence has yet been reported, basal tumors are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ductal, Breast
Share to Carcinoma, Lobular

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Medullary

Share to Lymphatic Metastasis

Share to Multivariate Analysis

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Identifiers

PMID: 18398844
DOI: 10.1002/ijc.23518

Genes

ERBB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How basal are triple-negative breast cancers?PMID 18398844Read ↗

What Is the Difference Between Triple-Negative and Basal Breast Cancers?Semantic proximity Read ↗

Basal breast cancer: a complex and deadly molecular subtype.Semantic proximity Read ↗

Update on triple‐negative breast cancers – highlighting subtyping update and treatment implicationSemantic proximity Read ↗

Basal-Like Breast Cancer: A Critical ReviewSemantic proximity Read ↗

Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice.Semantic proximity Read ↗

Triple Negative Breast Cancer Subclassified by Immunohistochemistry: Correlation with Clinical and Pathological Outcomes in Patients Receiving Neoadjuvant ChemotherapySemantic proximity Read ↗

The Omics of Triple-Negative Breast CancersSemantic proximity Read ↗

Triple-negative breast cancer: current state of the art.Semantic proximity Read ↗

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapiesSemantic proximity Read ↗

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.Semantic proximity Read ↗

Targeting basal-like breast cancers.Semantic proximity Read ↗

Basal phenotype breast cancer: implications for treatment and prognosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.